Complete Filing Data
PLIANT THERAPEUTICS, INC. reported Stockholders Equity of $181.21 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean PLIANT THERAPEUTICS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$149.3M | -$210.3M | -$161.3M | -$123.3M | -$97.3M | -$41.5M | -$631.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$336.0K | -$24.0K | $2.3M | -$1.8M | -$169.0K | -$31.0K | -$1.0K |
| Research And Development Expense | $109.2M | $169.3M | $127.8M | $96.9M | $77.5M | $66.2M | $47.4M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$336.0K | -$24.0K | $2.3M | -$1.8M | -$169.0K | -$31.0K | -$1.0K |
| Operating Income Loss | -$156.4M | -$228.4M | -$184.1M | -$127.2M | -$97.5M | -$41.6M | -$1.2M |
| Operating Expenses | $156.4M | $228.4M | $185.7M | $136.9M | $105.1M | $83.5M | $58.3M |
| General And Administrative Expense | $47.2M | $59.1M | $57.9M | $39.9M | $27.6M | $17.3M | $10.9M |
| Comprehensive Income Net Of Tax | -$149.7M | -$210.3M | -$159.0M | -$125.1M | -$97.4M | -$41.6M | -$632.0K |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $1.6M | $9.7M | $7.6M | $41.8M | $57.1M |
| Net Income Loss Available To Common Stockholders Basic | -$123.3M | -$97.3M | -$41.5M | -$6.9M | |||
| Income Taxes Receivable | $0.00 | $83.0K | $83.0K | $83.0K | $333.0K | ||
| Accrued Research And Development Expenses Current | $4.8M | $14.4M | $12.5M | $11.2M | $5.9M | ||
| Interest Expense Nonoperating | $2.6M | $3.0M | $1.3M | $791.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$26.3M | -$43.3M | -$56.2M | -$57.8M | -$55.9M | -$47.0M | -$41.5M | -$41.2M | -$37.5M | -$30.6M | -$29.5M | -$28.1M | -$27.0M | -$22.8M | -$22.9M | -$16.5M | -$17.0M | $11.0M | -$13.3M | -$15.5M | -$14.0M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $35.0K | -$160.0K | -$162.0K | $1.5M | -$128.0K | -$834.0K | $334.0K | -$910.0K | $627.0K | -$1.2M | -$309.0K | -$749.0K | -$10.0K | -$12.0K | $14.0K | $12.0K | -$89.0K | $60.0K | -$10.0K | $8.0K | $3.0K |
| Research And Development Expense | $17.9M | $32.2M | $43.4M | $47.8M | $45.6M | $37.1M | $32.3M | $33.0M | $29.3M | $24.6M | $26.3M | $20.9M | $21.1M | $19.2M | $18.5M | $16.9M | $17.5M | $13.9M | $10.8M | $13.1M | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $35.0K | -$160.0K | -$162.0K | $1.5M | -$128.0K | -$834.0K | $334.0K | -$910.0K | $627.0K | -$1.2M | -$309.0K | -$749.0K | -$10.0K | -$12.0K | $14.0K | $12.0K | -$89.0K | $60.0K | -$10.0K | $8.0K | |
| Operating Income Loss | -$28.3M | -$45.6M | -$58.9M | -$62.0M | -$60.6M | -$52.4M | -$47.7M | -$47.3M | -$42.1M | -$31.9M | -$29.6M | -$28.2M | -$27.1M | -$22.9M | -$22.9M | -$16.7M | -$17.0M | $11.0M | -$13.4M | -$15.7M | |
| Operating Expenses | $28.3M | $45.6M | $58.9M | $62.0M | $60.6M | $52.4M | $47.7M | $47.6M | $43.4M | $33.4M | $34.6M | $29.5M | $28.7M | $24.7M | $25.1M | $21.5M | $20.6M | $17.9M | $13.4M | $15.7M | |
| General And Administrative Expense | $10.3M | $13.4M | $15.5M | $14.3M | $15.0M | $15.2M | $15.3M | $14.6M | $14.2M | $8.8M | $8.3M | $8.6M | $7.7M | $5.5M | $6.6M | $4.6M | $3.0M | $4.0M | $2.6M | $2.6M | |
| Comprehensive Income Net Of Tax | -$26.3M | -$43.5M | -$56.3M | -$56.3M | -$56.0M | -$47.8M | -$41.2M | -$42.1M | -$36.9M | -$31.8M | -$29.9M | -$28.8M | -$27.1M | -$22.8M | -$22.8M | -$16.5M | -$17.1M | $11.1M | -$13.3M | -$15.5M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $248.0K | $1.3M | $1.5M | $5.0M | $1.2M | $1.6M | $1.8M | $2.2M | $4.8M | $3.6M | $28.9M | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$41.5M | -$41.2M | -$37.5M | -$30.6M | -$29.5M | -$28.1M | -$27.0M | -$22.8M | -$22.9M | -$16.5M | -$17.0M | $0.00 | -$14.6M | -$16.9M | |||||||
| Income Taxes Receivable | $83.0K | $77.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | ||||||||||
| Accrued Research And Development Expenses Current | $7.8M | $10.8M | $14.4M | $23.0M | $19.4M | $16.4M | $13.7M | $18.2M | $14.6M | ||||||||||||
| Interest Expense Nonoperating | $815.0K | $809.0K | $799.0K | $877.0K | $868.0K | $445.0K | $317.0K | $319.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $181.2M | $304.1M | $473.6M | $313.3M | $199.1M | $283.1M | -$76.3M | -$71.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $46.9M | $72.7M | $64.7M | $33.7M | $51.7M | $50.9M | $85.8M | $60.9M |
| Unrealized Gain Loss On Investments | -$24.0K | $2.3M | -$1.8M | -$169.0K | -$31.0K | -$1.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$25.7M | $8.0M | $31.0M | -$18.0M | $783.0K | -$34.9M | $24.9M | |
| Short Term Investments | $145.5M | $284.5M | $431.0M | $297.5M | $148.9M | $226.0M | $17.0M | |
| Retained Earnings Accumulated Deficit | -$859.4M | -$710.1M | -$499.7M | -$338.4M | -$215.1M | -$117.8M | -$76.3M | |
| Property Plant And Equipment Net | $2.9M | $5.5M | $3.6M | $4.5M | $4.6M | $4.3M | $4.1M | |
| Prepaid Expense And Other Assets Current | $4.5M | $6.5M | $11.3M | $7.1M | $6.8M | $4.5M | $1.7M | |
| Other Assets Noncurrent | $392.0K | $435.0K | $392.0K | $394.0K | $838.0K | $451.0K | $3.1M | |
| Liabilities Current | $16.4M | $33.2M | $28.5M | $23.9M | $16.8M | $11.6M | $8.2M | |
| Liabilities And Stockholders Equity | $225.2M | $396.9M | $512.2M | $350.6M | $221.2M | $295.5M | $119.1M | |
| Liabilities | $44.0M | $92.9M | $38.6M | $37.3M | $22.2M | $12.5M | $9.1M | |
| Cash And Cash Equivalents At Carrying Value | $45.4M | $71.2M | $63.2M | $33.7M | $51.7M | $50.9M | $85.8M | |
| Assets Current | $196.4M | $362.3M | $505.5M | $340.3M | $209.4M | $290.8M | $111.9M | |
| Assets | $225.2M | $396.9M | $512.2M | $350.6M | $221.2M | $295.5M | $119.1M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$15.0K | $321.0K | $345.0K | -$2.0M | -$201.0K | -$32.0K | -$1.0K | |
| Accounts Payable Current | $480.0K | $6.0M | $4.5M | $1.6M | $3.0M | $2.0M | $1.3M | |
| Additional Paid In Capital Common Stock | $1.04B | $1.01B | $973.0M | $653.7M | $414.3M | $400.9M | $0.00 | |
| Common Stock Value | $6.0K | $6.0K | $6.0K | $5.0K | $3.0K | |||
| Accrued Liabilities Current | $9.6M | $12.4M | $10.2M | $8.7M | $9.6M | $6.9M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $3.3M | $3.5M | $2.4M | $1.9M | $1.7M | $0.00 | $0.00 | |
| Operating Lease Right Of Use Asset | $24.0M | $27.2M | $1.2M | $5.4M | $6.3M | $0.00 | ||
| Operating Lease Liability Noncurrent | $27.7M | $29.4M | $0.00 | $3.4M | $5.3M | $0.00 | ||
| Operating Lease Liability Current | $1.4M | $542.0K | $1.3M | $2.5M | $1.9M | $0.00 | ||
| Reclassification Of Restricted Stock Awards From Liabilities To Common Stock Upon Vesting | $0.00 | $0.00 | $2.0K | $9.0K | $11.0K | $30.0K | ||
| Long Term Debt | $0.00 | $30.2M | $10.1M | $9.9M | $0.00 | |||
| Accounts Receivable Net Current | $0.00 | $2.0M | $2.0M | $9.3M | $7.1M | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $29.8M | $0.00 | $950.0K | $0.00 | |||
| Restricted Cash | $1.5M | $1.5M | $1.5M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $200.3M | $220.1M | $257.2M | $345.8M | $392.7M | $437.3M | $503.0M | $533.1M | $561.9M | $337.0M | $147.8M | $173.8M | $220.4M | $244.0M | $264.2M | $300.3M | $315.8M | -$64.8M | -$116.9M | -$102.7M | -$86.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $95.2M | $88.3M | $93.4M | $81.1M | $81.9M | $115.8M | $57.7M | $55.0M | $102.5M | $44.6M | $25.1M | $32.5M | $45.2M | $35.2M | $50.8M | $55.2M | $178.5M | $113.4M | $11.4M | $12.9M | ||||
| Unrealized Gain Loss On Investments | -$162.0K | -$834.0K | $636.0K | -$749.0K | $14.0K | $12.0K | -$89.0K | $60.0K | -$10.0K | $8.0K | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $20.7M | $51.1M | $68.8M | -$19.1M | -$63.0K | $27.6M | ||||||||||||||||||
| Short Term Investments | $148.1M | $176.1M | $213.7M | $324.9M | $356.2M | $368.1M | $465.9M | $500.2M | $474.8M | $315.6M | $138.5M | $145.7M | $175.8M | $208.8M | $213.3M | $238.8M | $134.0M | |||||||
| Retained Earnings Accumulated Deficit | -$835.8M | -$809.5M | -$766.2M | -$660.3M | -$602.6M | -$546.7M | -$458.6M | -$417.2M | -$376.0M | -$303.4M | -$272.7M | -$243.2M | -$190.6M | -$163.5M | -$140.7M | -$98.8M | -$82.3M | |||||||
| Property Plant And Equipment Net | $4.3M | $4.9M | $5.2M | $5.7M | $5.4M | $5.6M | $4.0M | $4.3M | $4.2M | $4.8M | $4.5M | $4.7M | $4.7M | $4.4M | $4.3M | $4.1M | $4.0M | |||||||
| Prepaid Expense And Other Assets Current | $3.8M | $4.6M | $5.5M | $5.5M | $10.9M | $7.5M | $10.6M | $8.9M | $7.5M | $4.2M | $4.9M | $5.8M | $5.8M | $4.8M | $4.2M | $6.5M | $8.2M | |||||||
| Other Assets Noncurrent | $392.0K | $391.0K | $427.0K | $427.0K | $437.0K | $392.0K | $392.0K | $672.0K | $644.0K | $397.0K | $913.0K | $835.0K | $831.0K | $630.0K | $451.0K | $451.0K | $451.0K | |||||||
| Liabilities Current | $17.6M | $20.6M | $28.2M | $40.0M | $30.9M | $30.4M | $27.4M | $29.5M | $23.2M | $26.2M | $22.6M | $18.3M | $12.9M | $10.9M | $10.3M | $11.0M | $12.0M | |||||||
| Liabilities And Stockholders Equity | $276.6M | $299.8M | $344.8M | $445.7M | $483.7M | $521.6M | $540.5M | $574.9M | $597.9M | $377.2M | $184.6M | $197.0M | $234.1M | $255.7M | $275.3M | $312.3M | $328.8M | |||||||
| Liabilities | $76.3M | $79.7M | $87.6M | $99.8M | $91.1M | $84.3M | $37.4M | $41.8M | $36.0M | $40.2M | $36.8M | $23.2M | $13.7M | $11.7M | $11.1M | $12.0M | $13.0M | |||||||
| Cash And Cash Equivalents At Carrying Value | $93.7M | $86.8M | $91.9M | $79.6M | $80.4M | $114.3M | $57.7M | $55.0M | $102.5M | $44.6M | $25.1M | $32.5M | $45.2M | $35.2M | $50.8M | $55.2M | $178.5M | |||||||
| Assets Current | $245.6M | $267.4M | $311.2M | $410.0M | $447.6M | $489.9M | $534.3M | $565.7M | $588.2M | $366.0M | $173.5M | $185.4M | $228.6M | $250.7M | $270.5M | $307.7M | $324.3M | |||||||
| Assets | $276.6M | $299.8M | $344.8M | $445.7M | $483.7M | $521.6M | $540.5M | $574.9M | $597.9M | $377.2M | $184.6M | $197.0M | $234.1M | $255.7M | $275.3M | $312.3M | $328.8M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $34.0K | -$1.0K | $159.0K | $848.0K | -$617.0K | -$489.0K | -$1.9M | -$2.2M | -$1.3M | -$2.5M | -$1.3M | -$950.0K | -$40.0K | -$30.0K | -$18.0K | -$18.0K | -$30.0K | |||||||
| Accounts Payable Current | $485.0K | $1.4M | $5.6M | $6.9M | $3.2M | $7.3M | $3.4M | $2.3M | $1.4M | $3.2M | $3.1M | $4.7M | $2.6M | $2.8M | $2.9M | $3.1M | $2.5M | |||||||
| Additional Paid In Capital Common Stock | $1.04B | $1.03B | $1.02B | $1.01B | $995.8M | $984.5M | $963.6M | $952.5M | $939.2M | $642.8M | $421.8M | $417.9M | $411.0M | $407.5M | $404.9M | $399.2M | $398.1M | |||||||
| Common Stock Value | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $1.0K | |||||
| Accrued Liabilities Current | $8.2M | $7.2M | $7.4M | $9.7M | $8.2M | $5.9M | $8.3M | $6.8M | $20.3M | $17.4M | $11.6M | $12.0M | $10.3M | $8.2M | $7.4M | $7.9M | $9.6M | |||||||
| Operating Lease Right Of Use Asset Amortization Expense | $813.0K | $681.0K | $609.0K | $244.0K | $348.0K | |||||||||||||||||||
| Operating Lease Right Of Use Asset | $24.8M | $25.6M | $26.4M | $28.1M | $28.9M | $24.2M | $1.8M | $4.2M | $4.8M | $6.0M | $5.6M | $6.1M | ||||||||||||
| Operating Lease Liability Noncurrent | $28.2M | $28.8M | $29.1M | $29.8M | $30.1M | $23.9M | $0.00 | $2.3M | $2.9M | $4.1M | $4.4M | $4.9M | ||||||||||||
| Operating Lease Liability Current | $1.2M | $1.2M | $771.0K | $322.0K | $98.0K | $773.0K | $2.1M | $2.2M | $2.4M | $2.6M | $2.0M | $2.0M | ||||||||||||
| Reclassification Of Restricted Stock Awards From Liabilities To Common Stock Upon Vesting | $1.0K | $2.0K | $4.0K | |||||||||||||||||||||
| Long Term Debt | $30.4M | $30.4M | $30.3M | $30.1M | $30.1M | $30.0M | $10.0M | $10.0M | $10.0M | $9.9M | $9.9M | |||||||||||||
| Accounts Receivable Net Current | $0.00 | $1.6M | $3.3M | $1.5M | $5.0M | $1.2M | $1.6M | $1.8M | $2.2M | $7.1M | $3.6M | |||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $23.7M | $0.00 | |||||||||||||||||||||
| Restricted Cash | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $26.2M | $37.6M | $44.5M | $22.6M | $10.4M | $3.9M | $1.8M |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $337.9M | $355.5M | $457.0M | $177.3M | $295.5M | $113.3M | $35.0M |
| Payments To Acquire Short Term Investments | $203.4M | $211.3M | $583.1M | $325.7M | $219.9M | $322.6M | $51.7M |
| Payments To Acquire Property Plant And Equipment | $374.0K | $3.8M | $921.0K | $1.8M | $2.0M | $1.5M | $964.0K |
| Net Cash Provided By Used In Operating Activities | -$128.3M | -$155.5M | -$116.4M | -$94.6M | -$75.4M | -$37.3M | -$2.8M |
| Net Cash Provided By Used In Investing Activities | $134.3M | $140.3M | -$127.0M | -$150.2M | $73.7M | -$210.9M | -$17.9M |
| Net Cash Provided By Used In Financing Activities | -$31.7M | $23.1M | $274.4M | $226.9M | $2.5M | $213.2M | $45.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.5M | -$4.7M | $3.7M | $294.0K | $2.3M | $2.8M | $1.5M |
| Increase Decrease In Accrued Liabilities | -$12.2M | $3.8M | $2.8M | $7.9M | $2.7M | $2.7M | $4.3M |
| Increase Decrease In Accounts Payable | -$5.5M | $1.4M | $3.0M | -$1.4M | $891.0K | $922.0K | -$1.3M |
| Increase Decrease In Other Noncurrent Assets | -$43.0K | $43.0K | $0.00 | -$201.0K | -$70.0K | $70.0K | -$232.0K |
| Increase Decrease In Accounts Receivable | $0.00 | -$2.0M | -$15.0K | -$7.3M | $2.2M | $7.1M | |
| Increase Decrease In Operating Lease Liability | -$876.0K | -$820.0K | -$2.7M | -$2.3M | -$1.8M | $0.00 | $0.00 |
| Proceeds From Issuance Initial Public Offering | $0.00 | $270.3M | $216.2M | $0.00 | $150.8M | $0.00 | |
| Payments Of Deferred Offering Costs | $0.00 | $847.0K | $557.0K | $457.0K | |||
| Proceeds From Issuances Of Common Stock Under Benefit Plans | $570.0K | $3.2M | $5.0M | $1.4M | $3.0M | ||
| Proceeds From Issuance Of Debt | $0.00 | $19.9M | $0.00 | $9.9M | $0.00 | ||
| Stock Issued During Period Value Share Based Compensation | $11.0K | $28.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $8.9M | $9.7M | $11.9M | $3.5M | $2.6M | $425.0K | |||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $83.5M | $113.4M | $102.6M | $41.4M | $77.3M | $0.00 | |||||||
| Payments To Acquire Short Term Investments | $14.1M | $52.4M | $276.6M | $39.2M | $64.8M | $11.0M | |||||||
| Payments To Acquire Property Plant And Equipment | $262.0K | $1.5M | $163.0K | $644.0K | $242.0K | $336.0K | |||||||
| Net Cash Provided By Used In Operating Activities | -$48.9M | -$30.3M | -$30.3M | -$20.5M | -$13.7M | -$12.8M | |||||||
| Net Cash Provided By Used In Investing Activities | $69.1M | $59.5M | -$174.2M | $1.5M | $12.2M | -$11.4M | |||||||
| Net Cash Provided By Used In Financing Activities | $498.0K | $21.8M | $273.3M | -$153.0K | $1.4M | $51.7M | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$995.0K | -$3.7M | $476.0K | -$1.0M | -$318.0K | $883.0K | |||||||
| Increase Decrease In Accrued Liabilities | -$4.8M | -$910.0K | -$538.0K | -$364.0K | -$2.1M | -$424.0K | |||||||
| Increase Decrease In Accounts Payable | -$338.0K | $2.3M | -$144.0K | $1.8M | $665.0K | $1.2M | |||||||
| Increase Decrease In Other Noncurrent Assets | -$8.0K | $0.00 | $0.00 | -$207.0K | $0.00 | -$233.0K | |||||||
| Increase Decrease In Accounts Receivable | $0.00 | $1.3M | -$749.0K | -$7.1M | $24.7M | ||||||||
| Increase Decrease In Operating Lease Liability | -$91.0K | -$363.0K | -$656.0K | -$275.0K | -$361.0K | ||||||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $270.3M | $0.00 | ||||||||||
| Payments Of Deferred Offering Costs | $0.00 | $586.0K | $204.0K | $0.00 | $364.0K | ||||||||
| Proceeds From Issuances Of Common Stock Under Benefit Plans | $498.0K | $1.9M | $3.7M | $51.0K | |||||||||
| Proceeds From Issuance Of Debt | $0.00 | $19.9M | $0.00 | ||||||||||
| Stock Issued During Period Value Share Based Compensation | $2.0K | $2.0K | $2.0K | $3.0K | $1.0K | $4.0K | $7.0K | $9.0K | $8.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 61.4M | 60.5M | 58.7M | 42.0M | 35.8M | 21.3M | 1.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 61.4M | 60.5M | 58.7M | 42.0M | 35.8M | 21.3M | 1.6M |
| Earnings Per Share Basic | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 |
| Earnings Per Share Diluted | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 |
| Common Stock Shares Outstanding | 61.4M | 60.9M | 59.9M | 48.9M | 36.1M | 35.6M | 1.8M |
| Common Stock Shares Issued | 61.4M | 60.9M | 59.9M | 48.9M | 36.1M | 35.6M | 1.8M |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 181.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 61.4M | 61.4M | 61.2M | 60.7M | 60.4M | 60.2M | 59.7M | 59.2M | 56.1M | 46.8M | 36.2M | 36.1M | 35.9M | 35.7M | 35.6M | 35.4M | 12.3M | 1.9M | 1.7M | 1.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 61.4M | 61.4M | 61.2M | 60.7M | 60.4M | 60.2M | 59.7M | 59.2M | 56.1M | 46.8M | 36.2M | 36.1M | 35.9M | 35.7M | 35.6M | 35.4M | 12.3M | 1.9M | 1.7M | 1.6M |
| Earnings Per Share Basic | $-0.43 | $-0.71 | $-0.92 | $-0.95 | $-0.92 | $-0.78 | $-0.70 | $-0.70 | $-0.67 | $-0.65 | $-0.82 | $-0.78 | $-0.75 | $-0.64 | $-0.64 | $-0.47 | $-1.39 | $0.00 | $-8.53 | $-10.82 |
| Earnings Per Share Diluted | $-0.43 | $-0.71 | $-0.92 | $-0.95 | $-0.92 | $-0.78 | $-0.70 | $-0.70 | $-0.67 | $-0.65 | $-0.82 | $-0.78 | $-0.75 | $-0.64 | $-0.64 | $-0.47 | $-1.39 | $0.00 | $-8.53 | $-10.82 |
| Common Stock Shares Outstanding | 61.4M | 61.4M | 61.4M | 60.8M | 60.4M | 60.3M | 59.9M | 59.2M | 59.0M | 48.7M | 36.2M | 36.2M | 36.0M | 35.9M | 35.7M | 35.5M | 35.4M | |||
| Common Stock Shares Issued | 61.4M | 61.4M | 61.4M | 60.8M | 60.4M | 60.3M | 59.9M | 59.2M | 59.0M | 48.7M | 36.2M | 36.2M | 36.0M | 35.9M | 35.7M | 35.5M | 35.4M | |||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $26.2M | $37.6M | $44.5M | $22.6M | $10.4M | $3.9M | $1.8M |
| Depreciation | $1.7M | $2.1M | $1.8M | $1.8M | $1.5M | $1.3M | $1.1M |
| Stock Issued During Period Value Stock Options Exercised | $1.4M | $3.0M | $442.0K | $174.0K | |||
| Interest And Other Income Expense Net | $11.4M | $21.1M | $24.1M | $4.7M | $272.0K | ||
| Stock Issued During Period Value Employee Benefit Plan | $570.0K | $3.2M | $5.0M | $1.4M | $3.0M | ||
| Capital Expenditures Incurred But Not Yet Paid | $112.0K | $236.0K | $0.00 | $0.00 | $57.0K | $188.0K | $159.0K |
| Interest Paid Net | $2.5M | $2.6M | $1.1M | $615.0K | $0.00 | ||
| Interest And Other Income Net | -$791.0K | $0.00 | $112.0K | $600.0K | |||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $2.0K | $9.0K | $11.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.4M | $6.4M | $8.9M | $8.9M | $10.6M | $9.7M | $10.4M | $13.0M | $11.9M | $4.8M | $3.4M | $3.5M | $2.8M | $2.3M | $2.6M | $1.2M | $786.0K | $425.0K | $480.0K | $506.0K | $312.0K |
| Depreciation | $400.0K | $400.0K | $448.0K | $500.0K | $600.0K | $513.0K | $500.0K | $400.0K | $452.0K | $500.0K | $400.0K | $455.0K | $400.0K | $400.0K | $359.0K | $300.0K | $300.0K | $312.0K | $300.0K | $200.0K | |
| Stock Issued During Period Value Stock Options Exercised | $334.0K | $3.7M | $808.0K | $446.0K | $51.0K | $702.0K | $372.0K | $1.4M | $3.0K | $177.0K | $26.0K | $14.0K | $132.0K | ||||||||
| Interest And Other Income Expense Net | $2.8M | $3.1M | $3.6M | $5.1M | $5.7M | $5.9M | $6.5M | $6.5M | $4.9M | $1.6M | $269.0K | $111.0K | |||||||||
| Stock Issued During Period Value Employee Benefit Plan | $72.0K | $0.00 | $498.0K | $543.0K | $684.0K | $1.9M | $774.0K | $334.0K | $3.7M | $808.0K | $446.0K | $51.0K | |||||||||
| Capital Expenditures Incurred But Not Yet Paid | $132.0K | $1.1M | $0.00 | ||||||||||||||||||
| Interest Paid Net | $723.0K | $501.0K | $282.0K | $0.00 | |||||||||||||||||
| Interest And Other Income Net | $1.3M | $96.0K | $111.0K | $68.0K | $73.0K | $63.0K | $127.0K | -$25.0K | $21.0K | ||||||||||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $1.0K | $1.0K | $2.0K | $2.0K | $2.0K |
Most recent annual filing with the SEC: March 11, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.